SG11202007942YA - Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor - Google Patents
Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses thereforInfo
- Publication number
- SG11202007942YA SG11202007942YA SG11202007942YA SG11202007942YA SG11202007942YA SG 11202007942Y A SG11202007942Y A SG 11202007942YA SG 11202007942Y A SG11202007942Y A SG 11202007942YA SG 11202007942Y A SG11202007942Y A SG 11202007942YA SG 11202007942Y A SG11202007942Y A SG 11202007942YA
- Authority
- SG
- Singapore
- Prior art keywords
- aav
- vectors
- associated virus
- uses therefor
- novel adeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635968P | 2018-02-27 | 2018-02-27 | |
| US201862635964P | 2018-02-27 | 2018-02-27 | |
| US201862663797P | 2018-04-27 | 2018-04-27 | |
| US201862663788P | 2018-04-27 | 2018-04-27 | |
| US201862667587P | 2018-05-06 | 2018-05-06 | |
| US201862667881P | 2018-05-07 | 2018-05-07 | |
| US201862667888P | 2018-05-07 | 2018-05-07 | |
| US201862667585P | 2018-05-29 | 2018-05-29 | |
| US201862677471P | 2018-05-29 | 2018-05-29 | |
| US201862677474P | 2018-05-29 | 2018-05-29 | |
| US201862703670P | 2018-07-26 | 2018-07-26 | |
| US201862703673P | 2018-07-26 | 2018-07-26 | |
| US201862722382P | 2018-08-24 | 2018-08-24 | |
| US201862722388P | 2018-08-24 | 2018-08-24 | |
| PCT/US2019/019861 WO2019169004A1 (en) | 2018-02-27 | 2019-02-27 | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202007942YA true SG11202007942YA (en) | 2020-09-29 |
Family
ID=67809202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202007942YA SG11202007942YA (en) | 2018-02-27 | 2019-02-27 | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210123073A1 (en) |
| EP (1) | EP3768695A4 (en) |
| JP (1) | JP7498665B2 (en) |
| KR (1) | KR20210006327A (en) |
| CN (1) | CN112236443A (en) |
| AU (1) | AU2019228504A1 (en) |
| BR (1) | BR112020017278A2 (en) |
| CA (1) | CA3091795A1 (en) |
| CL (1) | CL2020002201A1 (en) |
| IL (1) | IL276860A (en) |
| MA (1) | MA52087A (en) |
| MX (1) | MX2020008932A (en) |
| SG (1) | SG11202007942YA (en) |
| WO (1) | WO2019169004A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3356390T (en) | 2015-09-28 | 2021-04-21 | Univ Florida | Methods and compositions for antibody-evading virus vectors |
| BR112020020266A2 (en) | 2018-04-03 | 2021-01-19 | Stridebio, Inc. | VIRUSES WITH ANTIBODY EVASION |
| EP3884057A4 (en) * | 2018-12-21 | 2022-09-07 | The University of North Carolina at Chapel Hill | Optimized galc genes and expression cassettes and their use |
| CA3133453A1 (en) | 2019-03-21 | 2020-09-24 | Daniel Mccoy | Recombinant adeno-associated virus vectors |
| BR112022006530A2 (en) | 2019-10-17 | 2022-07-05 | Stridebio Inc | ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF NIEMANN-PICK TYPE C DISEASE |
| WO2021080991A1 (en) * | 2019-10-21 | 2021-04-29 | The Trustees Of The University Of Pennsylvania | Aav3b variants with improved production yield and liver tropism |
| US20230204595A1 (en) * | 2020-01-03 | 2023-06-29 | Sarepta Therapeutics, Inc. | Methods for analyzing aav capsid proteins |
| US20230151359A1 (en) * | 2020-03-09 | 2023-05-18 | University Of Massachusetts | Gene replacement therapy for foxg1 syndrome |
| JP2023531451A (en) | 2020-06-17 | 2023-07-24 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | Compositions and methods for treatment of gene therapy patients |
| EP4179097A1 (en) | 2020-07-13 | 2023-05-17 | The Trustees of The University of Pennsylvania | Compositions useful for treatment of charcot-marie-tooth disease |
| IL302127A (en) * | 2020-10-18 | 2023-06-01 | Univ Pennsylvania | Improved adeno-associated virus (aav) vector and uses therefor |
| CA3209779A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| EP4323520A1 (en) | 2021-04-12 | 2024-02-21 | The Trustees of The University of Pennsylvania | Compositions useful for treating spinal and bulbar muscular atrophy (sbma) |
| WO2023081807A1 (en) * | 2021-11-04 | 2023-05-11 | The Trustees of the University of Pennsylvania Penn Center for Innovation | Compositions and methods for reducing pcsk9 levels in a subject |
| TW202338086A (en) | 2022-01-10 | 2023-10-01 | 賓州大學委員會 | Compositions useful in treatment of metachromatic leukodystrophy |
| TW202340467A (en) | 2022-01-10 | 2023-10-16 | 賓州大學委員會 | Compositions and methods useful for treatment of c9orf72-mediated disorders |
| WO2023196892A1 (en) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004083441A2 (en) * | 2003-03-19 | 2004-09-30 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Random peptide library displayed on aav vectors |
| JP5054975B2 (en) | 2003-09-30 | 2012-10-24 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | Syngeneic strains of adeno-associated virus (AAV), sequences, vectors containing them and uses thereof |
| JP5702519B2 (en) * | 2005-04-07 | 2015-04-15 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | How to increase the function of an AAV vector |
| PT3198018T (en) * | 2014-09-24 | 2021-02-24 | Hope City | Adeno-associated virus vector variants for high efficiency genome editing and methods thereof |
| CA2969145A1 (en) * | 2014-11-26 | 2016-06-02 | The Regents Of The University Of California | Therapeutic compositions comprising transcription factors and methods of making and using the same |
| CN109661470A (en) | 2016-04-15 | 2019-04-19 | 宾夕法尼亚州大学信托人 | New A AV8 mutant capsids and composition containing it |
| IL305149A (en) * | 2016-07-26 | 2023-10-01 | Biomarin Pharm Inc | Novel adeno-associated virus capsid proteins |
| MX2019001938A (en) * | 2016-08-15 | 2019-07-04 | Genzyme Corp | Methods for detecting aav. |
| JOP20190200A1 (en) * | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | Compositions useful in treatment of spinal muscular atrophy |
| SG11201907714UA (en) * | 2017-02-28 | 2019-09-27 | Univ Pennsylvania | Adeno-associated virus (aav) clade f vector and uses therefor |
-
2019
- 2019-02-27 KR KR1020207027462A patent/KR20210006327A/en active Search and Examination
- 2019-02-27 CA CA3091795A patent/CA3091795A1/en active Pending
- 2019-02-27 SG SG11202007942YA patent/SG11202007942YA/en unknown
- 2019-02-27 WO PCT/US2019/019861 patent/WO2019169004A1/en unknown
- 2019-02-27 US US16/975,545 patent/US20210123073A1/en active Pending
- 2019-02-27 MX MX2020008932A patent/MX2020008932A/en unknown
- 2019-02-27 AU AU2019228504A patent/AU2019228504A1/en active Pending
- 2019-02-27 BR BR112020017278-2A patent/BR112020017278A2/en unknown
- 2019-02-27 JP JP2020545159A patent/JP7498665B2/en active Active
- 2019-02-27 MA MA052087A patent/MA52087A/en unknown
- 2019-02-27 EP EP19760152.9A patent/EP3768695A4/en active Pending
- 2019-02-27 CN CN201980029022.1A patent/CN112236443A/en active Pending
-
2020
- 2020-08-23 IL IL276860A patent/IL276860A/en unknown
- 2020-08-26 CL CL2020002201A patent/CL2020002201A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019228504A1 (en) | 2020-09-10 |
| US20210123073A1 (en) | 2021-04-29 |
| EP3768695A4 (en) | 2022-04-06 |
| CL2020002201A1 (en) | 2020-12-18 |
| IL276860A (en) | 2020-10-29 |
| JP7498665B2 (en) | 2024-06-12 |
| EP3768695A1 (en) | 2021-01-27 |
| CN112236443A (en) | 2021-01-15 |
| WO2019169004A9 (en) | 2019-10-31 |
| MA52087A (en) | 2021-06-02 |
| MX2020008932A (en) | 2020-10-01 |
| BR112020017278A2 (en) | 2020-12-22 |
| JP2021515548A (en) | 2021-06-24 |
| WO2019169004A8 (en) | 2019-12-05 |
| WO2019169004A1 (en) | 2019-09-06 |
| CA3091795A1 (en) | 2019-09-06 |
| KR20210006327A (en) | 2021-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276859A (en) | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor | |
| IL276860A (en) | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor | |
| IL286911A (en) | Recombinant adeno-associated viruses and uses thereof | |
| ZA201905407B (en) | Adeno-associated virus (aav) clade f vector and uses therefor | |
| IL286464A (en) | Recombinant adeno-associated virus vectors | |
| IL282885A (en) | Aav viral vectors and uses thereof | |
| IL263801B1 (en) | Novel adeno-associated virus capsid proteins | |
| ZA201801657B (en) | Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same | |
| TR201901582T4 (en) | Capsid | |
| EP4303225A3 (en) | Polyploid adeno-associated virus vectors and methods of making and using the same | |
| CA2921232A1 (en) | Adeno-associated virus factor viii vectors | |
| IL287214A (en) | Adeno-associated virus vector formulations and methods | |
| EP3943503A4 (en) | Adeno-associated virus having variant capsid protein and use thereof | |
| EP3575398A4 (en) | Mutant of adeno-associated virus (aav) capsid protein | |
| IL286831A (en) | Adeno-associated virus with engineered capsid | |
| EP4061427A4 (en) | Adeno-associated viral vector variants | |
| IL286725A (en) | Engineered adeno-associated (aav) vectors for transgene expression | |
| EP3790979A4 (en) | Adeno-associated virus (aav) delivery of anti-fam19a5 antibodies | |
| IL289489A (en) | Chemically-modified adeno-associated virus | |
| EP4048794A4 (en) | Triple function adeno-associated virus (aav) vectors for the treatment of c9orf72 associated diseases | |
| SG11201704919SA (en) | Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) | |
| SG11202006169PA (en) | Adeno-associated virus (aav) vector having hybrid hgf gene introduced thereto | |
| AU2019902377A0 (en) | AAV capsid polypeptides and AAV vectors | |
| EP3751000A4 (en) | Improved adeno-associated virus vector | |
| AU2020904687A0 (en) | Adeno-associated virus capsids and vectors |